Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1999 1
2004 1
2005 1
2006 1
2010 1
2011 2
2014 2
2015 2
2020 1
2024 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
Matta MK, Florian J, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Yang Y, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG. Matta MK, et al. JAMA. 2020 Jan 21;323(3):256-267. doi: 10.1001/jama.2019.20747. JAMA. 2020. PMID: 31961417 Free PMC article. Clinical Trial.
Secondary outcomes were the maximum plasma concentrations of oxybenzone, octocrylene, homosalate, octisalate, and octinoxate over days 1 through 21. RESULTS: Among 48 randomized participants (mean [SD] age, 38.7 [13.2] years; 24 women [50%]; 23 white [48%], 23 African Amer …
Secondary outcomes were the maximum plasma concentrations of oxybenzone, octocrylene, homosalate, octisalate, and octinoxate over day …
Mitigation of ultraviolet-induced erythema and inflammation by para-hydroxycinnamic acid in human skin.
Janson WP, Breyfogle LE, Bierman JC, Chew ZY, Ehrman MC, Oblong JE. Janson WP, et al. Int J Cosmet Sci. 2025 Feb;47(1):91-100. doi: 10.1111/ics.13002. Epub 2024 Aug 13. Int J Cosmet Sci. 2025. PMID: 39138602 Free PMC article. Clinical Trial.
RESULTS: Across the three independent studies, pHCA alone or in combination with Nam showed a significant mitigation of UV-induced erythema, barrier disruption, and levels of the surface inflammatory biomarkers IL-1RA/IL-1alpha. The cinnamate analogue Octinoxate did not re …
RESULTS: Across the three independent studies, pHCA alone or in combination with Nam showed a significant mitigation of UV-induced erythema, …
Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens.
Stanfield JW, Feldman SR, Levitt J. Stanfield JW, et al. J Drugs Dermatol. 2006 Apr;5(4):321-4. J Drugs Dermatol. 2006. PMID: 16673798 Clinical Trial.
METHODS: We tested the sun protection factor of a hydroquinone formulation (Lustra-Ultra, TaroPharma, Hawthorne, NY) containing avobenzone 3%, and octinoxate 7.5% according to the FDA Sunscreen Monograph on 20 volunteer subjects. We also determined the UVR absorbance spect …
METHODS: We tested the sun protection factor of a hydroquinone formulation (Lustra-Ultra, TaroPharma, Hawthorne, NY) containing avobenzone 3 …
Evaluation of a prescription strength 4% hydroquinone/10% L-ascorbic acid treatment system for normal to oily skin.
Bruce S, Watson J. Bruce S, et al. J Drugs Dermatol. 2011 Dec;10(12):1455-61. J Drugs Dermatol. 2011. PMID: 22134571 Clinical Trial.
The system also contains vitamin E, witch hazel, aloe barbadensis leaf juice, penetration-enhancing ingredients, micronized zinc oxide, and octinoxate. METHODS: Patients with minimal or mild facial photodamage and hyperpigmentation, and normal to oily facial skin, used the …
The system also contains vitamin E, witch hazel, aloe barbadensis leaf juice, penetration-enhancing ingredients, micronized zinc oxide, and …
Decontamination of the skin with absorbing materials.
Lademann J, Patzelt A, Schanzer S, Richter H, Gross I, Menting KH, Frazier L, Sterry W, Antoniou C. Lademann J, et al. Skin Pharmacol Physiol. 2011;24(2):87-92. doi: 10.1159/000322305. Epub 2010 Nov 30. Skin Pharmacol Physiol. 2011. PMID: 21116121 Clinical Trial.
12 results